Chronic lesion activity and disability progression in secondary progressive multiple sclerosis

• Gavin Giovannoni,
• Nathalie Franchimont,
• Li Zhu,
• Douglas L Arnold,
• Nolan Campbell,
• Arie Gafson,
• Shibeshih Belachew,
• Vanessa Beynon,
• Ilena C George,
• Colm Elliott,
• Jun Ke,
• Huaihou Chen,
• Chunlei Ke,
• Matthew Scaramozza,
• Daniel P Bradley

Affiliations

Gavin Giovannoni

neurology professor

Nathalie Franchimont

Biogen Inc, Cambridge, Massachusetts, USA

Li Zhu

Department of Gastroenterology and Hepatology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China

Douglas L Arnold

McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada

Nolan Campbell

Biogen, Cambridge, Massachusetts, USA

Arie Gafson

University College London, Institute of Neurology; Barts and The London School of Medicine and Dentistry

Shibeshih Belachew

7Biogen Idec Inc, Cambridge, Massachusetts, USA

Vanessa Beynon

Global Research & Development, Biogen, Cambridge, Massachusetts, USA

Ilena C George

Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA

Colm Elliott

NeuroRx Research, Montreal, Quebec, Canada

Jun Ke

Biostatistics, Biogen Inc, Cambridge, Massachusetts, USA

Huaihou Chen

Biostatistics, Biogen Inc, Cambridge, Massachusetts, USA

Chunlei Ke

Biostatistics, Biogen Inc, Cambridge, Massachusetts, USA

Matthew Scaramozza

Global Research & Development, Biogen, Cambridge, Massachusetts, USA

Daniel P Bradley

Clinical Sciences, Biogen, Cambridge, Massachusetts, USA